Osteopontin in Metastatic Breast Cancer Patients

Status Completed

Clinical Trial Summary

OPN plays an important role in various aspects of malignancy, particularly those involved in tissue invasion and metastasis, and OPN levels have been associated with aggressive¬ness in several cancer types, including breast cancer. Tumor response to treatment is a predictor of prognosis and overall survival for cancer patient population the investigators assigned osteopontin as potential contributors in breast cancer.

Clinical Trial Description

Analysis of polymorphisms in the OPN regulatory region:

The PCR amplification of the promoter regulatory region from the extracted DNA by using the following primers -3 (forward primer 5" -CAA GCT ACT GCA TAC TCG AAA TCA CA-3" ; reverse primer 5" - ACA ACC AAG CCC TCC CAG AAT TTA-3" ). PCR was performed using 50 ng DNA as a template under the following conditions: 95°C for 10 min, then 36 cycles of 94°C for 30 s, an annealing temperature for 60 s, and 72°C for 60 s, with a final extension at 72°C for 15 min. After affinity membrane purification using the QIAquick Gel Extraction kit (Qiagen, Carlsbad, CA, USA), the PCR products were subjected to cycle sequencing with the respective forward and reverse primer using an automated ABI 310 DNA sequencer.

Measurement of serum level of osteopontin:

OPN level were measured using Enzyme linked immnosorbent (ELISA) Kit supplied by IBL (Immuno-Biological laboratories Co. Ltd., Japan). 30 normal females were conducted with matched age with a median osteopontine serum level of 15 so, this level was assigned as a cut off value.

Pretreatment serum level and polymorphism of oteopontine was correlated with different clinicopathological criteria of the patients, response to the treatment, PFS and OS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04274504
Study type	Observational [Patient Registry]
Source	Mansoura University
Contact
Status	Completed
Phase
Start date	January 2015
Completion date	November 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04618900` - Osteotome-mediated Sinus Floor Elevation With or Without Grafting Material	N/A
Recruiting	`NCT04003558` - Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
Recruiting	`NCT06114030` - Clinical and Radiographical Evaluation of CAD-CAM Crowns With and Without Deep Margin Elevation	N/A
Completed	`NCT05866289` - Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure
Not yet recruiting	`NCT06388395` - Clinical Performance of All-on-4 PEEK and Conventional Prostheses	N/A
Completed	`NCT06242639` - Metal-ceramic Fixed Partial Dentures Fabricated With Laser Sintering
Recruiting	`NCT03595423` - SPAnish Aortic VALVE Multicentric Study
Completed	`NCT03523364` - Survival Rate of All Ceramic Restorations Treated With Air-Water-Blasting Protocol
Recruiting	`NCT05822505` - Monocer AOANJRR Registry-nested Study
Completed	`NCT03239509` - 15 Years Outcomes Following Bioprosthetic vs Mechanical Aortic Valve Replacement Between 50-65 Years
Completed	`NCT04749953` - Maxillary Sinus Floor Augmentation With Different Grafting Materials	N/A
Completed	`NCT03510065` - Prevision® PMCF Study
Not yet recruiting	`NCT05812066` - Clinical Assessment of All Ceramic Single-retainer Using Upper Canine as Abutment With Minimum Preparation on the Lingual Surface, to Replace the Upper Lateral Incisor and Will be Compared With the All Ceramic Single-retainer Using Upper Central Incisor.	N/A
Recruiting	`NCT05818891` - Multicenter Mpact DM France